Hemodialysis Associated to Higher Incidence of In Stent Thrombosis

Original title: Impact of hemodialysis on local vessel healing and thrombus formation after drug-eluting stent implantation. Reference: Akihide Konishi, et al.  Journal of Cardiology 2014;64:25-31

 

Even though the benefit of DES implantation to the general population is undeniable, it has been proved lower in hemodialysis patients (HD); the reason behind this phenomenon remains unclear.

121 patients received angioplasty with DES implantation, 25 were in hemodialysis. Patients underwent 8-month follow-up coronary angiography with optical coherence tomography (OCT). After propensity matching, the risk of thrombus formation was 6 times higher in HD patients. Events rate was also higher in this group (mean 426 days).

OCT analysis showed no differences in neointimal thickness, neointimal area, strut coverage or apposition. In-stent thrombus formation was significantly higher in HD patients (61% vs. 19%; p=0.004). Clopidogrel was less effective after hemodialysis, but not aspirin.

Conclusion

HD is a potential risk factor in the presence of in stent thrombosis after DES implantation. Systemic alterations such as the diminished efficacy of clopidogrel and vessel characteristics after HD may contribute to a higher incidence of thrombus attachment leading to events after DES implantation.

Editorial Comment

This study shows higher asymmetry and higher in-stent thrombus attachment incidence in HD patients, as well as reduced antiplatelet effect of clopidogrel after HD. This increases post procedural events risk and calls for improved stents and post HD antiplatelet administration, either clopidogrel or a new one.

Courtesy of Dr. Carlos Fava
Interventional Cardiologist
Favaloro Foundation
Buenos Aires – Argentina

Carlos Fava

More articles by this author

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...